Glenmark gets USFDA nod for menopause symptom relief drug
Glenmark Pharmaceuticals has received final approval from the US health regulator for generic version of Nordisk Inc's VAGIFEM, which is used for pro17-09-2018
17-09-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sub: Glenmark Pharmaceuticals receives ANDA approval for Estradiol Vaginal Inserts USP, 10 mcg17-09-2018
Glenmark arm gets USFDA nod for generic version of asthma drug
Glenmark Pharma's subsidiary has secured marketing authorisation in Germany for generic version of GlaxoSmithKline's Seretide Accuhaler, which is use10-09-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sub: Glenmark secures marketing authorization in Germany for its generic version of Seretide Accuhaler10-09-2018
Glenmark to boost cash flows, pare debt as it eyes a lighter balance sheet
Pharma major is monetising assets through licensing arrangements, restructuring operations04-09-2018
Notice Of 40Th Annual General Meeting To Be Held On September 28, 2018
Further to our letter dated 21st August, 2018, enclosed please find herewith the Notice Convening the 40th Annual General Meeting of the Company scheduled to be held on Friday, 28th September, 2018 for your information and record.04-09-2018
Glenmark inks licensing pact for marketing Tiotropium Bromide DPI in Europe
Glenmark Pharmaceuticals Europe has entered into an exclusive licensing agreement for marketing generic Tiotropium Bromide dry powder inhaler, used i29-08-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sub: Glenmark enters into an exclusive licensing agreement to commercialize generic Tiotropium Bromide dry powder inhaler in Western Europe29-08-2018
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Enclosed please find herewith the Postal Ballot Notice and Ballot Form being sent to the shareholders to consider Ordinary Resolution under Section 188 of the Companies Act, 2013 and Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 or any amendment or re-enactment thereof, and any other provisions of the said Act or regulation, as may be applicable for the transfer of the Company's Active Pharmaceutical...24-08-2018
From Glenmark to Cipla, Indian firms see rise in rate of drug recalls in US
The reasons behind recall could vary from contamination (cross-batch, air-borne, dosage mix up, container, impurities) to wrong labelling, discolouration of tablets, non-standard quality24-08-2018